Identification

Name
RU81843
Accession Number
DB04495  (EXPT00324)
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
Not Available
Categories
UNII
Not Available
CAS number
Not Available
Weight
Average: 579.5806
Monoisotopic: 579.213436969
Chemical Formula
C30H34N3O7P
InChI Key
GGPXNASQNUOIPB-NSOVKSMOSA-N
InChI
InChI=1S/C30H34N3O7P/c1-21(34)31-28(19-22-12-16-26(17-13-22)40-41(37,38)39)29(35)32-27-9-5-6-18-33(30(27)36)20-23-10-14-25(15-11-23)24-7-3-2-4-8-24/h2-4,7-8,10-17,27-28H,5-6,9,18-20H2,1H3,(H,31,34)(H,32,35)(H2,37,38,39)/t27-,28-/m0/s1
IUPAC Name
(2S)-2-[(1-hydroxyethylidene)amino]-N-[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]-3-[4-(phosphonooxy)phenyl]propanimidic acid
SMILES
[H][[email protected]@](CC1=CC=C(OP(O)(O)=O)C=C1)(N=C(C)O)C(O)=N[[email protected]@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
TargetActionsOrganism
UProto-oncogene tyrosine-protein kinase SrcNot AvailableHuman
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
447518
PubChem Substance
46507314
ChemSpider
394581
BindingDB
14689
ChEMBL
CHEMBL25826
HET
843
PDB Entries
1o42

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0027 mg/mLALOGPS
logP3.02ALOGPS
logP3.89ChemAxon
logS-5.3ALOGPS
pKa (Strongest Acidic)2.16ChemAxon
pKa (Strongest Basic)1.55ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area152.25 Å2ChemAxon
Rotatable Bond Count10ChemAxon
Refractivity154.51 m3·mol-1ChemAxon
Polarizability58.7 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption-0.7687
Blood Brain Barrier-0.5549
Caco-2 permeable-0.6979
P-glycoprotein substrateSubstrate0.8915
P-glycoprotein inhibitor IInhibitor0.5447
P-glycoprotein inhibitor IINon-inhibitor0.7094
Renal organic cation transporterNon-inhibitor0.8525
CYP450 2C9 substrateNon-substrate0.6525
CYP450 2D6 substrateNon-substrate0.7926
CYP450 3A4 substrateSubstrate0.604
CYP450 1A2 substrateNon-inhibitor0.8756
CYP450 2C9 inhibitorNon-inhibitor0.7248
CYP450 2D6 inhibitorNon-inhibitor0.8604
CYP450 2C19 inhibitorNon-inhibitor0.6628
CYP450 3A4 inhibitorInhibitor0.646
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8827
Ames testNon AMES toxic0.6655
CarcinogenicityNon-carcinogens0.8406
BiodegradationNot ready biodegradable0.947
Rat acute toxicity2.5645 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.7779
hERG inhibition (predictor II)Inhibitor0.8522
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Dipeptides
Alternative Parents
Phenylalanine and derivatives / N-acyl-alpha amino acids and derivatives / Alpha amino acid amides / Biphenyls and derivatives / Phenyl phosphates / Amphetamines and derivatives / Phenoxy compounds / Caprolactams / Azepanes / Fatty amides
show 9 more
Substituents
Alpha-dipeptide / Phenylalanine or derivatives / N-acyl-alpha amino acid or derivatives / Alpha-amino acid amide / Biphenyl / Phenyl phosphate / Aryl phosphate / Aryl phosphomonoester / Amphetamine or derivatives / Alpha-amino acid or derivatives
show 26 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available

Targets

Kind
Protein
Organism
Human
Pharmacological action
Unknown
General Function
Sh3/sh2 adaptor activity
Specific Function
Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion recept...
Gene Name
SRC
Uniprot ID
P12931
Uniprot Name
Proto-oncogene tyrosine-protein kinase Src
Molecular Weight
59834.295 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235]

Drug created on June 13, 2005 07:24 / Updated on December 01, 2017 15:28